Medtronic presents new data on minimed™ 780g system on fixed meal dosing and real-world time in range across wide variety of users

Dublin and san diego , june 23, 2023 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the minimed™ 780g system. these latest data sets, which evaluated the system across a wide range of users, including historically challenging younger patients, those not meeting glycemic goals, and individuals using a simplified meal announcement leveraging fixed carbohydrate amounts instead of exact carb calculations, found that the proprietary meal detection™ technology supported time in range outcomes that exceed consensus guidelines of 70 percent.
MDT Ratings Summary
MDT Quant Ranking